Evidence map›Paper›PMID 35684380›Full record

ReviewMolecules (Basel, Switzerland)2022

Three-Dimensional Bioprinting of Decellularized Extracellular Matrix-Based Bioinks for Tissue Engineering.

Chun-Yang Zhang, Chao-Ping Fu, Xiong-Ya Li, Xiao-Chang Lu, Long-Ge Hu, Ranjith Kumar Kankala, Shi-Bin Wang, Ai-Zheng Chen

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Biomaterials for extrusion-based bioprinting and biomedical applications.Frontiers in bioengineering and biotechnology · 2024
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chun-Yang ZhangInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China.
Chao-Ping FuInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China.ORCID 0000-0002-4757-6889
Xiong-Ya LiInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China.
Xiao-Chang LuInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China.
Long-Ge HuInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China.
Ranjith Kumar KankalaInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China.ORCID 0000-0003-4081-9179
Shi-Bin WangInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China.
Ai-Zheng ChenInstitute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, China.ORCID 0000-0002-5840-3406

Funding

National Natural Science Foundation of China No. 2018YFB1105600
6 · The paper itself

Abstract

Three-dimensional (3D) bioprinting is one of the most promising additive manufacturing technologies for fabricating various biomimetic architectures of tissues and organs. In this context, the bioink, a critical element for biofabrication, is a mixture of biomaterials and living cells used in 3D printing to create cell-laden structures. Recently, decellularized extracellular matrix (dECM)-based bioinks derived from natural tissues have garnered enormous attention from researchers due to their unique and complex biochemical properties. This review initially presents the details of the natural ECM and its role in cell growth and metabolism. Further, we briefly emphasize the commonly used decellularization treatment procedures and subsequent evaluations for the quality control of the dECM. In addition, we summarize some of the common bioink preparation strategies, the 3D bioprinting approaches, and the applicability of 3D-printed dECM bioinks to tissue engineering. Finally, we present some of the challenges in this field and the prospects for future development.

Indexed as

BioprintingDecellularized Extracellular MatrixExtracellular MatrixPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsDecellularized Extracellular Matrix3D bioprintingbioinkdecellularized extracellular matrixtissue engineering

Identifiers

PMID35684380
PMCPMC9182049

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.